2018
DOI: 10.1128/aac.00147-18
|View full text |Cite
|
Sign up to set email alerts
|

Therapeutic Efficacy of Bumped Kinase Inhibitor 1369 in a Pig Model of Acute Diarrhea Caused by Cryptosporidium hominis

Abstract: Recent reports highlighting the global significance of cryptosporidiosis among children have renewed efforts to develop control measures. We evaluated the efficacy of bumped kinase inhibitor (BKI) 1369 in the gnotobiotic piglet model of acute diarrhea caused by , the species responsible for most human cases. Five-day treatment with BKI 1369 reduced signs of disease early during treatment compared to those of untreated animals. Piglets treated with BKI 1369 exhibited significant reductions of oocyst excretion, … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
41
0

Year Published

2018
2018
2024
2024

Publication Types

Select...
6
2
1

Relationship

3
6

Authors

Journals

citations
Cited by 38 publications
(47 citation statements)
references
References 27 publications
2
41
0
Order By: Relevance
“…BKI-1369 and BKI-1770 are lead compounds for the treatment of diarrhea caused by cryptosporidiosis in calves [15,17]. In addition, excellent BKI-1369 efficacy was demonstrated against Cystisospora suis infection in piglets [18], and in a pig model of acute diarrhea caused by Cryptosporidium hominis ([16].…”
Section: Discussionmentioning
confidence: 99%
“…BKI-1369 and BKI-1770 are lead compounds for the treatment of diarrhea caused by cryptosporidiosis in calves [15,17]. In addition, excellent BKI-1369 efficacy was demonstrated against Cystisospora suis infection in piglets [18], and in a pig model of acute diarrhea caused by Cryptosporidium hominis ([16].…”
Section: Discussionmentioning
confidence: 99%
“…There has been considerable recent investment in Cryptosporidium drug discovery and there are now several classes of compounds of lead, late lead, and preclinical status. These include bumped kinase inhibitors that target Cryptosporidium calcium-dependant protein kinase 1 (CDPK1) and are effective in several in vivo models of cryptosporidiosis, including gnotobiotic piglets and calf models, which showed a reduction in oocyst shedding and clinical signs [53,54]. Compounds that target tRNA synthetases, enzymes that charge tRNAs with their cognate amino acid for use in protein synthesis, have also proven effective against Cryptosporidium [55].…”
Section: Advances In Drug Discoverymentioning
confidence: 99%
“…While Giardia cysts made in mice excyst well, cysts made in vitro do not (57). Toxoplasma forms walled oocysts in cats, while Cryptosporidium forms oocysts in cows, mice, or gnotobiotic pigs (58-60). Oomycetes (water molds that cause potato blight) also have cellulose and chitin in their walls, but the amount of chitin is very small, and β- 1,3-glucan is also present (61).…”
Section: Discussionmentioning
confidence: 99%
“…MBP-fusion constructs were prepared by cloning the cDNA of a representative Luke(2) lectin (60 to 843-bp CDS of ACA1_377670) and a representative Jonah(1) lectin (70 to 1599-bp CDS of ACA1_164810) without their signal sequences into pMAL-p2x vector (New England Biolabs) for periplasmic expression in BL21-CodonPlus(DE3)-RIPL (Agilent Technologies, Lexington, MA) (34). For the MBP-fusion, the Leo CDS without the signal sequence (67 to 564-bp of ACA1_074730) was codon optimized (GenScript) and cloned into pMAL-p2x vector.…”
Section: Methodsmentioning
confidence: 99%